Economic burden of multiple sclerosis: a cross-sectional study in Iran

Abstract Background Multiple Sclerosis (MS) is a chronic debilitating disease that imposes a heavy socioeconomic burden on societies. This study aimed to determine the economic burden of MS on patients using the first (CinnoVex and ReciGen) and second (Fingolimod and Natalizumab) drug therapy lines....

Full description

Bibliographic Details
Published in:Health Economics Review
Main Authors: Mehdi Rezaee, Khosro Keshavarz, Sadegh Izadi, Abdosaleh Jafari, Ramin Ravangard
Format: Article
Language:English
Published: BMC 2022-01-01
Subjects:
Economic burden
Multiple sclerosis (MS)
Direct medical costs
Direct non-medical costs
Indirect costs
Online Access:https://doi.org/10.1186/s13561-021-00350-y

Internet

https://doi.org/10.1186/s13561-021-00350-y

Similar Items